---
reference_id: "PMID:35245290"
title: Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers-Danlos syndrome.
authors:
- Legrand A
- Guery C
- Faugeroux J
- Fontaine E
- Beugnon C
- Gianfermi A
- Loisel-Ferreira I
- Verpont MC
- Adham S
- Mirault T
- Hadchouel J
- Jeunemaitre X
journal: PLoS Genet
year: '2022'
doi: 10.1371/journal.pgen.1010059
content_type: abstract_only
---

# Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers-Danlos syndrome.
**Authors:** Legrand A, Guery C, Faugeroux J, Fontaine E, Beugnon C, Gianfermi A, Loisel-Ferreira I, Verpont MC, Adham S, Mirault T, Hadchouel J, Jeunemaitre X
**Journal:** PLoS Genet (2022)
**DOI:** [10.1371/journal.pgen.1010059](https://doi.org/10.1371/journal.pgen.1010059)

## Content

1. PLoS Genet. 2022 Mar 4;18(3):e1010059. doi: 10.1371/journal.pgen.1010059. 
eCollection 2022 Mar.

Comparative therapeutic strategies for preventing aortic rupture in a mouse 
model of vascular Ehlers-Danlos syndrome.

Legrand A(1)(2), Guery C(1), Faugeroux J(1), Fontaine E(1), Beugnon C(1), 
Gianfermi A(1), Loisel-Ferreira I(1), Verpont MC(3), Adham S(2), Mirault 
T(1)(2)(4), Hadchouel J(5), Jeunemaitre X(1)(2).

Author information:
(1)Université de Paris, INSERM, U970, Paris Cardiovascular Research Centre, 
Paris, France.
(2)Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 
Service de Génétique et Centre de Référence des Maladies Vasculaires Rares, 
Paris, France.
(3)Sorbonne Université, INSERM, U1155, Plateforme d'Imagerie et de Cytométrie, 
Paris, France.
(4)Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, 
Service de Médecine Vasculaire, Paris, France.
(5)Sorbonne Université, INSERM, U1155, Hôpital Tenon, Paris, France.

Vascular Ehlers-Danlos syndrome is a rare inherited disorder caused by genetic 
variants in type III collagen. Its prognosis is especially hampered by 
unpredictable arterial ruptures and there is no therapeutic consensus. We 
created a knock-in Col3a1+/G182R mouse model and performed a complete genetic, 
molecular and biochemical characterization. Several therapeutic strategies were 
also tested. Col3a1+/G182R mice showed a spontaneous mortality caused by 
thoracic aortic rupture that recapitulates the vascular Ehlers-Danlos syndrome 
with a lower survival rate in males, thin non-inflammatory arteries and an 
altered arterial collagen. Transcriptomic analysis of aortas showed upregulation 
of genes related to inflammation and cell stress response. Compared to water, 
survival rate of Col3a1+/G182R mice was not affected by beta-blockers 
(propranolol or celiprolol). Two other vasodilating anti-hypertensive agents 
(hydralazine, amlodipine) gave opposite results on aortic rupture and mortality 
rate. There was a spectacular beneficial effect of losartan, reversed by the 
cessation of its administration, and a marked deleterious effect of exogenous 
angiotensin II. These results suggest that blockade of the renin angiotensin 
system should be tested as a first-line medical therapy in patients with 
vascular Ehlers-Danlos syndrome.

DOI: 10.1371/journal.pgen.1010059
PMCID: PMC8926273
PMID: 35245290 [Indexed for MEDLINE]

Conflict of interest statement: The authors have declared that no competing 
interests exist.